These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 38785471)

  • 1. Optimizing Access to Unrelated Donors in Canada: Re-Examining the Importance of Donor Factors on Outcomes Following Hematopoietic Cell Transplantation.
    Parmar G; Seftel MD; Ganz K; Blake J; Holovati JL; Allan DS
    Curr Oncol; 2024 Apr; 31(5):2542-2551. PubMed ID: 38785471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real-World Data Showing Trends and Outcomes by Race and Ethnicity in Allogeneic Hematopoietic Cell Transplantation: A Report from the Center for International Blood and Marrow Transplant Research.
    Auletta JJ; Kou J; Chen M; Bolon YT; Broglie L; Bupp C; Christianson D; Cusatis RN; Devine SM; Eapen M; Hamadani M; Hengen M; Lee SJ; Moskop A; Page KM; Pasquini MC; Perez WS; Phelan R; Riches ML; Rizzo JD; Saber W; Spellman SR; Stefanski HE; Steinert P; Tuschl E; Yusuf R; Zhang MJ; Shaw BE
    Transplant Cell Ther; 2023 Jun; 29(6):346.e1-346.e10. PubMed ID: 36924931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Donor-Recipient Matching for KIR Genotypes Reduces Chronic GVHD and Missing Inhibitory KIR Ligands Protect against Relapse after Myeloablative, HLA Matched Hematopoietic Cell Transplantation.
    Faridi RM; Kemp TJ; Dharmani-Khan P; Lewis V; Tripathi G; Rajalingam R; Daly A; Berka N; Storek J; Masood Khan F
    PLoS One; 2016; 11(6):e0158242. PubMed ID: 27341514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes from unrelated donor hematopoietic stem cell transplantation.
    Perez LE
    Cancer Control; 2011 Oct; 18(4):216-21. PubMed ID: 21976240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unrelated donor choices for allogeneic hematopoietic cell transplantation in Canada: an evaluation of factors influencing donor selection.
    Greco-Stewart V; Kiernan J; Killeen D; Haun S; Mercer D; Young K; Liwski RS; Allan DS
    Transfusion; 2018 Mar; 58(3):718-725. PubMed ID: 29277913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved access to better HLA-matched hematopoietic cells for allogeneic transplant: analysis of donors and cord blood units selected for Canadian patients in 2018.
    Greco-Stewart V; Elmoazzen H; Morris G; Guo Y; Langdon C; Mercer D; Dibdin N; Allan DS
    Transfusion; 2020 Jul; 60(7):1508-1518. PubMed ID: 32319688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current donor selection strategies for allogeneic hematopoietic cell transplantation.
    Timofeeva OA; Philogene MC; Zhang QJ
    Hum Immunol; 2022 Oct; 83(10):674-686. PubMed ID: 36038413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving Unrelated Donor Equity: Assessing Mismatched Donor Opportunities with Real-World Data in a Minority-Predominant Cohort.
    Hammami MB; Verceles JA; Goldfinger M; Shah N; Sica RA; Mantzaris I; Kornblum N; Konopleva M; Shastri A; Shapiro LC; Feldman EJ; Gritsman K; Verma A; Cooper DL
    Transplant Cell Ther; 2024 May; 30(5):544.e1-544.e8. PubMed ID: 38417677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Who Is a Better Donor for Recipients of Allogeneic Hematopoietic Cell Transplantation: A Young HLA-Mismatched Haploidentical Relative or an Older Fully HLA-Matched Sibling or Unrelated Donor?
    Karam E; Laporte J; Solomon SR; Morris LE; Zhang X; Holland HK; Bashey A; Solh MM
    Biol Blood Marrow Transplant; 2019 Oct; 25(10):2054-2060. PubMed ID: 31173900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes in Hematopoietic Stem Cell Transplantation for Congenital Amegakaryocytic Thrombocytopenia.
    Cancio M; Hebert K; Kim S; Aljurf M; Olson T; Anderson E; Burroughs L; Vatsayan A; Myers K; Hashem H; Hanna R; Horn B; Prestidge T; Boelens JJ; Boulad F; Eapen M
    Transplant Cell Ther; 2022 Feb; 28(2):101.e1-101.e6. PubMed ID: 34670170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Donor Selection for Allogeneic Hematopoietic Cell Transplantation.
    Fleischhauer K; Tran TH; Meisel R; Mytilineos J; Dreger P; Kröger N
    Dtsch Arztebl Int; 2023 Apr; 120(15):261-268. PubMed ID: 36949660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Existence of HLA-Mismatched Unrelated Donors Closes the Gap in Donor Availability Regardless of Recipient Ancestry.
    Chowdhury AS; Maiers M; Spellman SR; Deshpande T; Bolon YT; Devine SM
    Transplant Cell Ther; 2023 Nov; 29(11):686.e1-686.e8. PubMed ID: 37586457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allogeneic hematopoietic cell transplantation with cord blood versus mismatched unrelated donor with post-transplant cyclophosphamide in acute myeloid leukemia.
    Dholaria B; Labopin M; Sanz J; Ruggeri A; Cornelissen J; Labussière-Wallet H; Blaise D; Forcade E; Chevallier P; Grassi A; Zubarovskaya L; Kuball J; Ceballos P; Ciceri F; Baron F; Savani BN; Nagler A; Mohty M
    J Hematol Oncol; 2021 May; 14(1):76. PubMed ID: 33941226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haploidentical
    Brissot E; Labopin M; Ehninger G; Stelljes M; Brecht A; Ganser A; Tischer J; Kröger N; Afanasyev B; Finke J; Elmaagacli A; Einsele H; Mohty M; Nagler A
    Haematologica; 2019 Mar; 104(3):524-532. PubMed ID: 30361416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current HLA testing recommendations to support HCT.
    Yu N; Askar M; Wadsworth K; Gragert L; Fernández-Viña MA
    Hum Immunol; 2022 Oct; 83(10):665-673. PubMed ID: 35798627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haplotype Motif-Based Models for KIR-Genotype Informed Selection of Hematopoietic Cell Donors Fail to Predict Outcome of Patients With Myelodysplastic Syndromes or Secondary Acute Myeloid Leukemia.
    Schetelig J; Baldauf H; Koster L; Kuxhausen M; Heidenreich F; de Wreede LC; Spellman S; van Gelder M; Bruno B; Onida F; Lange V; Massalski C; Potter V; Ljungman P; Schaap N; Hayden P; Lee SJ; Kröger N; Hsu K; Schmidt AH; Yakoub-Agha I; Robin M
    Front Immunol; 2020; 11():584520. PubMed ID: 33542712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allogeneic hematopoietic stem cell transplantation from sibling and unrelated donors in pediatric patients with sickle cell disease-A single center experience.
    Kogel F; Hakimeh D; Sodani P; Lang P; Kühl JS; Hundsdoerfer P; Künkele A; Eggert A; Oevermann L; Schulte JH
    Pediatr Transplant; 2021 Mar; 25(2):e13892. PubMed ID: 33098344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of allogeneic haematopoietic stem cell transplantation from HLA-matched and alternative donors: a European Society for Blood and Marrow Transplantation registry retrospective analysis.
    Shouval R; Fein JA; Labopin M; Kröger N; Duarte RF; Bader P; Chabannon C; Kuball J; Basak GW; Dufour C; Galimard JE; Polge E; Lankester A; Montoto S; Snowden JA; Styczynski J; Yakoub-Agha I; Mohty M; Nagler A
    Lancet Haematol; 2019 Nov; 6(11):e573-e584. PubMed ID: 31477550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T-cell replete haploidentical donor transplantation using post-transplant CY: an emerging standard-of-care option for patients who lack an HLA-identical sibling donor.
    Bashey A; Solomon SR
    Bone Marrow Transplant; 2014 Aug; 49(8):999-1008. PubMed ID: 24842530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective analysis to determine barriers to allogeneic hematopoietic cell transplantation in patients with acute leukemia.
    Nath K; Lee J; Elko TA; Levy L; Preston E; Devlin SM; Ponce DM; Lin RJ; Shaffer BC; Cho C; Politikos I; Jakubowski AA; Park JH; Rampal R; Perales MA; Tallman MS; Barker JN; Berman E; Tamari R; Stein E; Giralt SA; Gyurkocza B
    Am J Hematol; 2023 Dec; 98(12):1869-1876. PubMed ID: 37688521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.